title: Hemoglobin A1c testing is associated with improved pancreas utilization for transplant.
abstract: BACKGROUND
  Aging, higher prevalence of diabetes, worsening obesity, and hyperglycemia among potential donors increase the likelihood that pancreata will be declined by transplant centers. Hemoglobin A1c testing, also known as glycated hemoglobin testing, identifies a donor's average blood glucose concentration for the preceding 2 to 3 months and is the standard test for identifying prolonged periods of hyperglycemia.
  
  
  OBJECTIVE
  To compare pancreas utilization rates before and after implementation of hemoglobin A1c testing.
  
  
  METHODS
  A retrospective study of data from the New York Organ Donor Network was conducted. Potential donors were defined as standard criteria donors who had no history of diabetes and were not seropositive for hepatitis B or C. Criteria for "ideal" potential pancreas donors were based on age, body mass index, lipase level, and terminal creatinine level. Potential donors who did not meet the criteria for ideal donors were considered "expanded" potential pancreas donors. Pancreas utilization rate was defined as the number of pancreata transplanted divided by the number of potential pancreas donors.
  
  
  RESULTS
  Of 779 standard criteria donors, 691 (89%) were potential pancreas donors: 251 ideal (36%) and 440 expanded (64%) donors. In 2005 and 2006, before hemoglobin A1c testing, pancreas utilization rates were 21% and 18%, respectively. In 2008, 2009, and 2010, after hemoglobin A1c testing was incorporated, utilization rates were 27%, 28%, and 32%, respectively. Utilization of ideal donors increased from 33% to 51% (P= .003), and utilization of expanded donors increased from 11% to 17% (P= .05). Pancreas utilization increased 51.0%, and pancreas discards decreased 50.8% with the implementation of hemoglobin A1c testing.
  
  
  CONCLUSIONS
  Hemoglobin A1c testing may increase utilization of ideal and expanded criteria pancreata.
authors: New York Organ Donor Network, NY, USA.
authors: Maritza
authors: M
authors: Torres-Quinones
authors: Jeffrey
authors: J
authors: Stern
authors: Nicholas
authors: N
authors: Seals
authors: Gysel
authors: G
authors: Giglio
authors: Kathryn
authors: K
authors: Meza
authors: Kristin Delli
authors: KD
authors: Carpini
authors: Nikolina
authors: N
authors: Icitovic
authors: Waheed
authors: W
authors: Tajik
authors: David
authors: D
authors: O'Hara
authors: Harvey
authors: H
authors: Lerner
authors: Michael J
authors: MJ
authors: Goldstein
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009518:New York; D010179:Pancreas; D012189:Retrospective Studies; D018570:Risk Assessment; D014015:Tissue Banks; D009927:Tissue and Organ Procurement
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human